Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Discover how cold exposure therapy might boost insulin sensitivity and lower blood sugar in people with diabetes. Scientific evidence is still unfolding.
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.
Explore how diabetes stigma in healthcare can hinder patient support and empowerment. Learn to recognize signs of stigma, understand its impact, and seek out stigma-free...
Myths and misconceptions about diabetes can cause added anxiety and stress for people living with the condition. Here we debunk some common diabetes myths and offer...
Pfizer propels clinical trials for danuglipron, a novel oral GLP-1 medication for obesity and type 2 diabetes, with promising preliminary results for A1C and weight loss.
Explore the role of artificial intelligence in diabetic retinopathy detection with Eyenuk's innovative technology. Here we also examine the disputed effects of GLP-1s on...
New research reveals a higher dementia risk in early-onset diabetes. Preventing prediabetes progression may be key to mitigating this risk.
Medtronic has announced that Medicare now covers its new MiniMed 780G automated insulin pump with the Guardian 4 sensor, enhancing diabetes management with automatic...
Explore the future of diabetes care, highlighting novel therapies and technologies. This article delves into CGM advances, once-weekly insulin, prevention therapies, and...
Author Christine Fallabel, who has had type 1 diabetes since 2000, shares a powerful perspective on what she’s felt like living with the condition. Fallabel and others...
At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...
Explore how beans can play a pivotal role in managing diabetes. Learn about the health benefits, including fiber, protein, and low GI, and the best types to include in...
A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...
Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...
PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.
Trying to figure out the best nutrition options as a person with diabetes can be a daunting task, and often there are mixed messages about what the best food options are.
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.
A panel shared insights at the ADA’s 83rd Scientific Sessions on incorporating hypoglycemia as a quality measure in diabetes. Each expert noted the importance of...
Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...
In this ADA session, experts discussed comprehensive therapies, coordinated care, and the role of pharmacists in improving your health.

Pages